Mayo Clinic Upgrades Orchestrate With OMOP Oncology to Standardize Cancer Data

Overview

• Mayo Clinic said Orchestrate now implements the OMOP Oncology model to convert complex cancer information into a consistent, analysis-ready format.
• The standardized data include deidentified tumor characteristics, biomarkers, staging, treatments, progression, and outcomes.
• The framework unifies inputs from diagnoses and lab results along with imaging, pathology, and radiology reports already integrated on the platform.
• Mayo plans to add tokenization later in 2026 to link deidentified records across care settings for a longitudinal view of patient journeys.
• Nemesis Health contributed to developing these capabilities on Orchestrate, which launched in 2025 to support faster trial design and real‑world evidence generation.